In a time of increasingly personalized healthcare, Elizabeth Philp has established herself as a significant force of innovation, especially in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a push to make bespoke medications more accessible, questioning